Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Anna FagottiMaria Gabriella FerrandinaGiuseppe VizzielliTina PasciutoFrancesco FanfaniValerio GallottaPasquale Alessandro MargaritiVito ChianteraBarbara CostantiniSalvatore Gueli AllettiFrancesco CosentinoGiovanni ScambiaPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Neoadjuvant chemotherapy and primary debulking surgery have the same efficacy when used at their maximal possibilities, but the toxicity profile is different.
Keyphrases
- neoadjuvant chemotherapy
- minimally invasive
- locally advanced
- coronary artery bypass
- lymph node
- sentinel lymph node
- surgical site infection
- rectal cancer
- squamous cell carcinoma
- oxidative stress
- heart rate
- radiation therapy
- resistance training
- acute coronary syndrome
- coronary artery disease
- early stage
- percutaneous coronary intervention